Turtlemint IPO subscribed 32% on day one. QIBs led at 51%, while retail and NIIs lagged. The ₹4,513 crore valuation and anchor list of 12 schemes set the stage for a June 29 listing.
Alpha Score of 57 reflects moderate overall profile with strong momentum, weak value, strong quality. Based on 3 of 4 signals — score is capped at 90 until remaining data ingests.
Turtlemint's initial public offering reached a 32% subscription rate by early afternoon on its first day of bidding. Investors placed bids for 1.04 crore shares against the total offer size of 3.29 crore shares.
Qualified institutional buyers (QIBs) carried the weight. They subscribed 51% of their reserved portion, bidding for 90.32 lakh shares against the 1.78 crore shares set aside for them.
Retail individual investors (RIIs) moved more slowly. They subscribed 21% of their quota, placing bids for 12.80 lakh shares out of 60.49 lakh reserved.
Non-institutional investors (NIIs) barely participated. They covered just 1% of their 90.72 lakh share allocation, with only 73,892 bids.
The IPO combines a fresh issue of shares worth ₹660.7 crore with an offer-for-sale (OFS) of up to 1.46 crore shares from promoters and existing shareholders. At the upper end of the ₹144-152 price band, the insurtech company carries a valuation of ₹4,513 crore, roughly $475 million.
Turtlemint plans to deploy the fresh capital toward technology infrastructure, product development, marketing, and working capital. It also aims to pursue inorganic growth opportunities.
Before the IPO opened, the company raised ₹397.2 crore from anchor investors. It allotted 2.61 crore equity shares to seven domestic mutual funds through 12 schemes. ICICI Prudential, Bank of India, and Bandhan Bank were among the domestic funds that anchored the round. Societe Generale, 360 One, Amansa Holdings, BNP Paribas, and Citi Group also participated.
Following the bidding period, Turtlemint will tentatively list on both the BSE and NSE on June 29.
The first-day subscription pattern shows institutional conviction. QIBs covered more than half their quota. Retail and high-net-worth investors held back. The 1% NII participation suggests that segment is not yet sold on the valuation. The next two days will determine whether the book fills without institutional overhang. The anchor list, which includes both domestic mutual funds and global names, provides a credibility floor. Whether that translates into broader demand depends on how the price band sits against Turtlemint's growth trajectory and the insurtech sector's multiples.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.